Skip to main content
. 2015 Sep 4;6(31):30939–30956. doi: 10.18632/oncotarget.5132

Figure 5. Effects of B5 on the Trx system.

Figure 5

Cells were treated with 0, 4, 16 and 32 μM B5 for 48 h. A. TrxR activity in cell lysates was determined by SC-TrxR assay. Data were presented as the percentage of control. B. Trx and TrxR protein levels were analyzed by SDS-PAGE and western blotting. C. The mRNA levels of Trx and TrxR were measured by RT-PCR; GAPDH was used as an internal control. D. Trx redox status was determined by non-reduced SDS-PAGE and western blotting analysis; GAPDH was used as the internal control. All data are representatives of three independent experiments.

HHS Vulnerability Disclosure